Vemurafenib and cutaneous adverse events - report of five cases

• मुख्य लेखकों: Giselle de Barros Silva (लेखक), Adriana Pessoa Mendes (लेखक), Mariana Petaccia de Macedo (लेखक), Clóvis Antônio Lopes Pinto (लेखक), Ivana Lameiras Gibbons (लेखक), João Pedreira Duprat Neto (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Sociedade Brasileira de Dermatologia, 2015-06-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

AbstractVemurafenib is a selective inhibitor of V600E-mutant BRAF protein used to treat metastatic and unresectable melanoma. Clinical trials have shown increased overall survival and progression-free survival in patients treated with Vemurafenib. However, cutaneous adverse events are common during...